BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,457,000 | +3.7% | 36,100 | 0.0% | 0.02% | +10.0% |
| Q2 2022 | $5,260,000 | +22.9% | 36,100 | 0.0% | 0.02% | +42.9% |
| Q1 2022 | $4,280,000 | -16.4% | 36,100 | -2.8% | 0.01% | -6.7% |
| Q4 2021 | $5,120,000 | -1.4% | 37,150 | -0.6% | 0.02% | -6.2% |
| Q3 2021 | $5,193,000 | +51.4% | 37,381 | +5.8% | 0.02% | +45.5% |
| Q2 2021 | $3,429,000 | +54.3% | 35,321 | +8.6% | 0.01% | +37.5% |
| Q1 2021 | $2,223,000 | -23.0% | 32,530 | -3.4% | 0.01% | -20.0% |
| Q4 2020 | $2,887,000 | +20.0% | 33,687 | -9.0% | 0.01% | 0.0% |
| Q3 2020 | $2,406,000 | -16.3% | 37,015 | -5.8% | 0.01% | -16.7% |
| Q2 2020 | $2,873,000 | +86.4% | 39,296 | -13.2% | 0.01% | +71.4% |
| Q1 2020 | $1,541,000 | -37.5% | 45,289 | 0.0% | 0.01% | -22.2% |
| Q4 2019 | $2,466,000 | +9.1% | 45,289 | -16.4% | 0.01% | 0.0% |
| Q3 2019 | $2,261,000 | -35.5% | 54,200 | -32.2% | 0.01% | -30.8% |
| Q2 2019 | $3,503,000 | -19.9% | 80,000 | -5.9% | 0.01% | -18.8% |
| Q1 2019 | $4,375,000 | – | 85,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |